A phase III clinical study of Amphetamine (HLD-900) for the treatment of binge eating disorder
Phase of Trial: Phase III
Latest Information Update: 05 Apr 2016
At a glance
- Drugs Amfetamine (Primary)
- Indications Binge-Eating Disorder
- Focus Therapeutic Use
- 05 Apr 2016 According to a Highland Therapeutics media release, this trial is expected to initiate in the second half of 2016.
- 17 Feb 2016 This trial is planned to be initiated in the year 2016.
- 17 Feb 2016 New trial record